Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (247)	1/29/2003 11:39:13 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

AGIX Is up 10% with the volume now over 1.35M (about 8x its daily average) It had a public offering of 7.2M of its common at $6.25, all of it offered by the company. The underwriters Morgan Stanley, Lehman Brothers, Lazard Freres and others, have a 30-day option to purchase another 1.08M additional shares.(Only to cover over-allotments, if any.<g>) AGIX announced earlier this month that it is proceeding with its Phase III (ARISE)of AGI-1067, for the treatment of ASHD According to Marc A. Pfeffer, M.D., Ph.D., Co-Chairman of the ARISE Steering Committee and Professor of Medicine at Brigham and Women's Hospital, Harvard Medical School, "AGI-1067 represents a new approach to the treatment of heart and vascular disease by targeting the underlying inflammatory process." (Also recently brought to the lime light by reports of increased C reactive protein in patients with ASHD lacking other risk factors like hypercholesterolemia or hypertension.) AGIX had $41.M or about $1.50 in cash/share prior to the present offering which is intended to raise close to $45M The insiders hold close to 50% of the shares, but had done significant selling lately. Institutions that hold more than 125% of the float have reportedly done some extra buying.<g>The float is less than 15M. siliconinvestor.com The stock needs to close above its Jan.24 H of 7.30 before it can test the resistance at the 7.75 level from Jan.14 siliconinvestor.com Bernard

To: Jibacoa who wrote (247)	2/11/2003 3:50:04 PM
From: Jibacoa	Respond to of 3722

SUPG Is up 14.03% with volume now above 458K (about 2x its daily average) It had a good start this morning after announcing that it has been issued a U.S. Patent entitled "Injectable Pharmaceutical Composition Comprising Coated Particles of Camptothecin", which covers intravenous use of its Orathecin.(The drug is been used orally for treatment of pancreatic Ca.and has already received fast track designation from the FDA) It has continued to gain strength this afternoon and it seems it should close near the H for the day in spite of the DOW and the NAZ both now on negative territory after Uncle Al's appearance in Congress.<g> siliconinvestor.com The stock needs to close above its Jan.15 H of 4.05 before it can test its Nov.18 H at 4.84 siliconinvestor.com Bernard